Natera (NTRA) Stock Forecast & Price Target

Compare

1,168 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

NTRA Analyst Ratings

Strong Buy

13 Buy

1 Hold

0 Sell

Based on 14 analysts giving stock ratings to

Natera

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

NTRA Stock 12 Month Forecast

Average Price Target

$262.57

▲(39.78% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $262.57 with a high forecast of $300.00 and a low forecast of $215.00. The average price target represents a 39.78% change from the last price of $187.85.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"133":"$133","175":"$175","217":"$217","259":"$259","301":"$301"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$300.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":262.57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$262.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":215,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$215.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[133,175,217,259,301],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,200.17,207.84923076923076,215.52846153846153,223.2076923076923,230.88692307692307,238.56615384615384,246.2453846153846,253.92461538461538,261.6038461538461,269.2830769230769,276.9623076923077,284.64153846153846,292.3207692307692,{"y":300,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,200.17,204.97,209.76999999999998,214.57,219.37,224.17,228.97,233.76999999999998,238.57,243.37,248.17,252.97,257.77,{"y":262.57,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,200.17,201.3107692307692,202.45153846153846,203.59230769230768,204.7330769230769,205.87384615384616,207.01461538461538,208.1553846153846,209.29615384615383,210.43692307692308,211.5776923076923,212.71846153846153,213.85923076923078,{"y":215,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":155.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.65,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.36,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.69,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.58,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":161.61,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.93,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":234.25,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":229.09,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.1,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.17,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$300.00

Average Price Target$262.57

Lowest Price Target$215.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Kyle Mikson CFA

Canaccord Genuity

$285

Buy

51.72%

Upside

Reiterated

03/13/26

Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Natera (NASDAQ: NTRA) and Nektar Therapeutics (NASDAQ: NKTR)

William Bonello

Craig-Hallum

$224

Buy

19.24%

Upside

Reiterated

03/04/26

We are increasing our 2026 revenue estimate by 4% to reflect continued momentum in the business. Natera had pre-released Q4 revenue that was significantly higher than we had expected, due in part to prior period revenue, but also to continued strength across all lines of business - and particularly Signatera. The company also issued 2026 guidance that was 3% higher than our estimate (and 2% higher than consensus) at the midpoint. The midpoint of the 2026 revenue guide implies 25% growth (excluding 2025 true-ups). We would consider 25% growth to be a huge success, given the size of the company and the very difficult 2025 comp. However, with the stock trading at 10x 2026 revenue, we suspect that Natera will need to continue the trend of beats and raises for the stock to go up meaningfully from here.

Kallum Titchmarsh

Morgan Stanley

$265→$250

Buy

33.08%

Upside

Reiterated

03/03/26

Maintained Buy on Natera: DCF‑Backed Upside and Attractive Long‑Term Growth Profile Despite Lower Price Target

Mark Massaro

BTIG

$260

Buy

38.41%

Upside

Reiterated

03/03/26

Natera: Strong Execution, Growing Signatera MRD Franchise, and Multiple Catalysts Support Buy Rating and $260 Target

Brandon Couillard

Wells Fargo

$205→$215

Hold

14.45%

Upside

Reiterated

02/27/26

Natera price target raised to $215 from $205 at Wells FargoNatera price target raised to $215 from $205 at Wells Fargo

Daniel Brennan

TD Cowen

$280

Buy

49.06%

Upside

Reiterated

02/27/26

Natera: Underpenetrated Growth, Emerging Catalysts, and a Clear Path to Cash Flow Support a Buy Rating

Dan Leonard

UBS

$280→$290

Buy

54.38%

Upside

Reiterated

02/27/26

Natera price target raised to $290 from $280 at UBSNatera price target raised to $290 from $280 at UBS

Catherine Ramsey Schulte

Robert W. Baird

$239→$257

Buy

36.81%

Upside

Reiterated

02/27/26

Natera price target raised to $257 from $239 at BairdNatera price target raised to $257 from $239 at Baird

David Westenberg

Piper Sandler

$230

Buy

22.44%

Upside

Reiterated

02/27/26

Piper Sandler Keeps Their Buy Rating on Natera (NTRA)

Patrick B Donnelly

Citi

$300

Buy

59.70%

Upside

Reiterated

02/27/26

Citi Sticks to Its Buy Rating for Natera (NTRA)

Daniel Markowitz CFA

Evercore ISI

$250→$260

Buy

38.41%

Upside

Reiterated

02/27/26

Natera price target raised to $260 from $250 at Evercore ISINatera price target raised to $260 from $250 at Evercore ISI

Luke Sergott

Barclays

$270→$280

Buy

49.06%

Upside

Reiterated

02/27/26

Natera (NTRA) Gets a Buy from Barclays

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$275

Buy

46.39%

Upside

Reiterated

02/27/26

Jefferies Remains a Buy on Natera (NTRA)

Subbu Nambi

Guggenheim

$270

Buy

43.73%

Upside

Reiterated

02/26/26

Guggenheim Reaffirms Their Buy Rating on Natera (NTRA)

Casey Woodring

J.P. Morgan

$250→$260

Buy

38.41%

Upside

Reiterated

12/15/25

Natera price target raised to $260 from $250 at JPMorganNatera price target raised to $260 from $250 at JPMorgan

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Kyle Mikson CFA

Canaccord Genuity

$285

Buy

51.72%

Upside

Reiterated

03/13/26

Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Natera (NASDAQ: NTRA) and Nektar Therapeutics (NASDAQ: NKTR)

William Bonello

Craig-Hallum

$224

Buy

19.24%

Upside

Reiterated

03/04/26

Kallum Titchmarsh

Morgan Stanley

$265→$250

Buy

33.08%

Upside

Reiterated

03/03/26

Maintained Buy on Natera: DCF‑Backed Upside and Attractive Long‑Term Growth Profile Despite Lower Price Target

Mark Massaro

BTIG

$260

Buy

38.41%

Upside

Reiterated

03/03/26

Natera: Strong Execution, Growing Signatera MRD Franchise, and Multiple Catalysts Support Buy Rating and $260 Target

Brandon Couillard

Wells Fargo

$205→$215

Hold

14.45%

Upside

Reiterated

02/27/26

Natera price target raised to $215 from $205 at Wells FargoNatera price target raised to $215 from $205 at Wells Fargo

Daniel Brennan

TD Cowen

$280

Buy

49.06%

Upside

Reiterated

02/27/26

Natera: Underpenetrated Growth, Emerging Catalysts, and a Clear Path to Cash Flow Support a Buy Rating

Dan Leonard

UBS

$280→$290

Buy

54.38%

Upside

Reiterated

02/27/26

Natera price target raised to $290 from $280 at UBSNatera price target raised to $290 from $280 at UBS

Catherine Ramsey Schulte

Robert W. Baird

$239→$257

Buy

36.81%

Upside

Reiterated

02/27/26

Natera price target raised to $257 from $239 at BairdNatera price target raised to $257 from $239 at Baird

David Westenberg

Piper Sandler

$230

Buy

22.44%

Upside

Reiterated

02/27/26

Piper Sandler Keeps Their Buy Rating on Natera (NTRA)

Patrick B Donnelly

Citi

$300

Buy

59.70%

Upside

Reiterated

02/27/26

Citi Sticks to Its Buy Rating for Natera (NTRA)

Daniel Markowitz CFA

Evercore ISI

$250→$260

Buy

38.41%

Upside

Reiterated

02/27/26

Natera price target raised to $260 from $250 at Evercore ISINatera price target raised to $260 from $250 at Evercore ISI

Luke Sergott

Barclays

$270→$280

Buy

49.06%

Upside

Reiterated

02/27/26

Natera (NTRA) Gets a Buy from Barclays

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$275

Buy

46.39%

Upside

Reiterated

02/27/26

Jefferies Remains a Buy on Natera (NTRA)

Subbu Nambi

Guggenheim

$270

Buy

43.73%

Upside

Reiterated

02/26/26

Guggenheim Reaffirms Their Buy Rating on Natera (NTRA)

Casey Woodring

J.P. Morgan

$250→$260

Buy

38.41%

Upside

Reiterated

12/15/25

Natera price target raised to $260 from $250 at JPMorganNatera price target raised to $260 from $250 at JPMorgan

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Natera

3 Months

xxx

Success Rate

27/39 ratings generated profit

Average Return

+13.01%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +13.01% per trade.

1 Year

Puneet SoudaLeerink Partners

Success Rate

29/32 ratings generated profit

Average Return

+56.62%

reiterated a buy rating 7 months ago

Copying Puneet Souda's trades and holding each position for 1 Year would result in 90.63% of your transactions generating a profit, with an average return of +56.62% per trade.

2 Years

xxx

Success Rate

31/32 ratings generated profit

Average Return

+136.22%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 96.88% of your transactions generating a profit, with an average return of +136.22% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NTRA Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, NTRA has received 26 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. NTRA average Analyst price target in the past 3 months is 262.57.

Each month's total comprises the sum of three months' worth of ratings.

NTRA Financial Forecast

NTRA Earnings Forecast

Next quarter’s earnings estimate for NTRA is -$0.54 with a range of -$0.68 to -$0.27. The previous quarter’s EPS was $0.36. NTRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Sales Forecast

Next quarter’s sales forecast for NTRA is $617.54M with a range of $584.30M to $633.00M. The previous quarter’s sales results were $665.50M. NTRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Stock Forecast FAQ

What is NTRA’s average 12-month price target, according to analysts?

Based on analyst ratings, Natera’s 12-month average price target is 262.57.

What is NTRA’s upside potential, based on the analysts’ average price target?

Natera has 39.78% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is NTRA a Buy, Sell or Hold?

Natera has a consensus rating of Strong Buy which is based on 13 buy ratings, 1 hold ratings and 0 sell ratings.

What is Natera’s price target?

The average price target for Natera is 262.57. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $300.00 ,the lowest forecast is $215.00. The average price target represents 39.78% Increase from the current price of $187.85.

What do analysts say about Natera?

Natera’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of NTRA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Natera (NTRA) Stock Forecast & Price Target

NTRA Analyst Ratings

NTRA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Natera

NTRA Analyst Recommendation Trends

NTRA Financial Forecast

NTRA Earnings Forecast

NTRA Sales Forecast

NTRA Stock Forecast FAQ

Detailed List of Analyst Forecasts